Nurse Practitioner, Adult Health · Duarte, CA
NPI
1609220037
Since 2016
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1500 Duarte Rd
Duarte, CA, 91010
Phone (626) 256-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
390 services
Medicare patients, 2024
177
Average age 71
Drug cost, 2024
$5.6M
1,560 prescriptions
Company payments, 2025
$5,400
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rowena D Meyer was code 99214 (office e&m - established), 362 times for 168 patients. In total Rowena D Meyer billed 390 services in 10 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 362 | 168 | $67.76 | $25K |
By year: 2022 $25K for 352 services; 2023 $15K for 224 services; 2024 $26K for 390 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rowena D Meyer prescribed most often to Medicare patients was Letrozole, with 195 prescriptions and refills. In total Rowena D Meyer wrote 1,560 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 195 | 529 | 70 | $5,104 |
| Anastrozole Generic | 160 | 439 | 58 | $2,971 |
| Ibrance Palbociclib | 129 | 129 | 16 | $1.9M |
| Kisqali Ribociclib Succinate | 72 | 73 | Under 11 | $1.0M |
| Gabapentin Generic | 55 | 130 | 25 | $649 |
| Verzenio Abemaciclib | 53 | 53 | Under 11 | $806K |
| Exemestane Generic | 52 | 98 | 19 | $8,085 |
| Tamoxifen Citrate Generic | 49 | 139 | 21 | $1,362 |
| Eliquis Apixaban | 35 | 37 | Under 11 | $22K |
| Pantoprazole Sodium Generic | 34 | 68 | 12 | $200 |
| Truqap Capivasertib | 31 | 31 | Under 11 | $685K |
| Alendronate Sodium Generic | 29 | 65 | 11 | $181 |
| Famotidine Generic | 28 | 48 | 12 | $149 |
| Potassium Chloride Generic | 28 | 49 | 11 | $2,158 |
| Ondansetron Hcl Generic | 27 | 31 | 13 | $227 |
Brand drugs: 454 claims; generic drugs: 1,106 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rowena D Meyer $5,400 ($5,400 in general payments such as food, travel and fees) from 9 companies. The largest payer was Merck Sharp & Dohme LLC with $4,134.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 9 | $4,134 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $738 |
| Stemline Therapeutics Inc. | 9 | $161 |
| Gilead Sciences, Inc. GILD | 3 | $156 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $57.66 |
| Caris MPI, Inc. | 1 | $50.07 |
| Daiichi Sankyo Inc. 4568.T | 2 | $45.59 |
| Corcept Therapeutics CORT | 1 | $31.28 |
| Genentech USA, Inc. ROG.SW | 1 | $26.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.